Anxo Pharmaceutical Co (ROCO:6677) Days Sales Outstanding : 77.78 (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Anxo Pharmaceutical Co Days Sales Outstanding?

Anxo Pharmaceutical Co's average Accounts Receivable for the six months ended in Dec. 2023 was NT$210.9 Mil. Anxo Pharmaceutical Co's Revenue for the six months ended in Dec. 2023 was NT$494.8 Mil. Hence, Anxo Pharmaceutical Co's Days Sales Outstanding for the six months ended in Dec. 2023 was 77.78.

The historical rank and industry rank for Anxo Pharmaceutical Co's Days Sales Outstanding or its related term are showing as below:

ROCO:6677' s Days Sales Outstanding Range Over the Past 10 Years
Min: 49.54 Med: 63.8 Max: 84.12
Current: 81.93

During the past 11 years, Anxo Pharmaceutical Co's highest Days Sales Outstanding was 84.12. The lowest was 49.54. And the median was 63.80.

ROCO:6677's Days Sales Outstanding is ranked worse than
60.46% of 999 companies
in the Drug Manufacturers industry
Industry Median: 72.08 vs ROCO:6677: 81.93

Anxo Pharmaceutical Co's Days Sales Outstanding increased from Dec. 2022 (70.86) to Dec. 2023 (77.78).

Anxo Pharmaceutical Co Days Sales Outstanding Historical Data

The historical data trend for Anxo Pharmaceutical Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anxo Pharmaceutical Co Days Sales Outstanding Chart

Anxo Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

56.47

65.82

74.32

81.28

84.12

Anxo Pharmaceutical Co Semi-Annual Data
	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial													75.83	85.93	70.86	84.21	77.78

Competitive Comparison of Anxo Pharmaceutical Co's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Anxo Pharmaceutical Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Anxo Pharmaceutical Co's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Anxo Pharmaceutical Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Anxo Pharmaceutical Co's Days Sales Outstanding falls into.

Anxo Pharmaceutical Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Anxo Pharmaceutical Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (211.196	+	222.062)	/	2 )	/	939.944	*	365
=	216.629					/	939.944	*	365
=	84.12

Anxo Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (199.664	+	222.062)	/	2 )	/	494.758	*	365 / 2
=	210.863					/	494.758	*	365 / 2
=	77.78

Anxo Pharmaceutical Co (ROCO:6677) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Anxo Pharmaceutical Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Anxo Pharmaceutical Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Anxo Pharmaceutical Co (ROCO:6677) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Anxo Pharmaceutical Co Ltd (ROCO:6677) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

8th Floor-3, Nanjing East Road, No. 206, Section 2, Taipei City, TWN

Website

http://www.anxo.com.tw

Anxo Pharmaceutical Co Ltd is a drug manufacturer. The company is engaged in developing drugs which include prescription medication and consumer healthcare medication. The products of the company include cardiovascular system medication, central nervous system medication, diabetes medication, infectious medicine, and dermatology medication.

Anxo Pharmaceutical Co (ROCO:6677) Headlines

No Headlines